New research from Norway has revealed that diabetic lung cancer patients usually live longer than those patients without diabetes. After risk factors were taken into account, the survival rates for patients with lung cancer and diabetes mellitus in the study showed that almost twice as many lung cancer patients without diabetes died compared to those with diabetes.
The scientists from Trondheim University and the Norwegian University of Science and Technology, whose work was published in the Journal of Thoracic Oncology, examined survival rates for 1,677 lung cancer patients both with and without diabetes from different studies and registries in Norway.
They found that the one-year survival rate for patients with lung cancer and diabetes was 43 per cent as compared with 28 per cent for patients without diabetes. The two-year survival rates were shown to be 19 per cent and 11 per cent respectively, while the three-year rates were 3 per cent and 1 per cent respectively. However, the scientists admitted that the findings needed more research, and that the metabolic condition was not a justifiable reason for withholding regular cancer therapy.
The report stated that "Patients with lung cancer with diabetes mellitus have an increased survival compared with those without diabetes mellitus."
It added "Standard therapy should not be withheld from patients with diabetes mellitus provided they are otherwise fit, even if it may be considered a significant comorbidity."
Diabetics with lung cancer tend to live longer than non-diabetics
Tue, 18 Oct 2011
Your comments may be moderated. Please report any spam, illegal, offensive or libellous posts.
Also related to this storyHealthcare Professionals
Diabetes Online Community
Blood Glucose Monitoring System
Diabetes Insurance for Life, Travel and Health
Diabetes Book Reviews
Low Carb Diet
Prevention of Diabetes
Diabetes in India
Colon cancer risk increased by diabetes, says study
UK has bad record of treating pancreatic cancer says charity
Diabetic men linked with cancer risk
Cancer drug could cause heart problems in diabetic older women
Diabetes drug dapagliflozin could increase risk of cancer, says report
Actos suspended in France due to cancer risk
Ibuprofen to help fight cancer
People with diabetes at greater risk of cancer, according to report
Diabetes has negative effect on breast cancer patients
New study on link between prostate cancer and diabetes
Research into diabetes drug metformin as potential cancer treatment
Men with diabetes at greater risk of developing colon cancer
Diabetes drugs could help combat lung cancer
Diabetes and cancer research receives grant for small molecule study
Link found between diabetes drug Actos and bladder cancer
Diabetes drug can reduce lung cancer for smokers
Diabetes may reduce risk of prostate cancer
Diabetes causes greater risk of cancer for women
Diabetic medicines may increase risk of skewed results in cancer screenings
Study into cancer risk of type 2 diabetes
People with type 2 diabetes face increased risk of cancer
Diabetes patients face greater risk of colon cancer
Diabetes drug link to prostate cancer
Lung cancer prevention from diabetes drug
Cancer and diabetes risk from beer bellies